A phase 2 trial of the Car-T project BNT211 is withdrawn just months after it began.
ApexOnco Front Page
Recent articles
The company gets another odronextamab knockback, while a key fianlimab readout is postponed.
AstraZeneca celebrates success in the Echo trial in mantle cell lymphoma, but watch out for BeiGene.
The $1bn price tag for the preclinical Mariana Oncology shows that competition for assets in this space is fierce.
Hopes are high for petosemtamab head and neck data at ASCO, but what does a win look like?
Daiichi and AstraZeneca claim another breast cancer success, and further evidence of the ADC’s activity in very low HER2 expression.
A pipeline cull sees the US pharma joining AbbVie's exit, in the wake of Novartis’s big bet.
Abstract titles reveal some of ASCO’s key datasets.